Kohjin Bio Balance Sheet Health
Financial Health criteria checks 5/6
Kohjin Bio has a total shareholder equity of ¥3.3B and total debt of ¥2.2B, which brings its debt-to-equity ratio to 65.1%. Its total assets and total liabilities are ¥6.6B and ¥3.2B respectively. Kohjin Bio's EBIT is ¥597.0M making its interest coverage ratio 27.1. It has cash and short-term investments of ¥1.7B.
Key information
65.1%
Debt to equity ratio
JP¥2.18b
Debt
Interest coverage ratio | 27.1x |
Cash | JP¥1.73b |
Equity | JP¥3.34b |
Total liabilities | JP¥3.25b |
Total assets | JP¥6.59b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 177A's short term assets (¥3.4B) exceed its short term liabilities (¥2.4B).
Long Term Liabilities: 177A's short term assets (¥3.4B) exceed its long term liabilities (¥849.0M).
Debt to Equity History and Analysis
Debt Level: 177A's net debt to equity ratio (13.4%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 177A's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 177A's debt is well covered by operating cash flow (37.8%).
Interest Coverage: 177A's interest payments on its debt are well covered by EBIT (27.1x coverage).